title: Fluoxetine inhibition of CYP3A4 potentiating adrenal suppression and peptic ulcer disease from intra-articular triamcinolone injections.
authors.forename: Thorsten M
authors.initials: TM
authors.lastname: Leucker
authors.forename: Sanjeev
authors.initials: S
authors.lastname: Singh
authors.forename: Bryan K
authors.initials: BK
authors.lastname: Moffett
mesh_terms: D000309:Adrenal Insufficiency / Q000139:chemically induced* / Q000517:prevention & control; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D000928:Antidepressive Agents / Q000009:adverse effects; D051544:Cytochrome P-450 CYP3A; D065692:Cytochrome P-450 CYP3A Inhibitors; D005260:Female; D005473:Fluoxetine / Q000009:adverse effects*; D006801:Humans; D007270:Injections, Intra-Articular / Q000009:adverse effects; D010437:Peptic Ulcer / Q000139:chemically induced* / Q000188:drug therapy*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects; D016896:Treatment Outcome; D014221:Triamcinolone / Q000009:adverse effects*
chemical_list: D000893:Anti-Inflammatory Agents; D000928:Antidepressive Agents; D051544:Cytochrome P-450 CYP3A; D065692:Cytochrome P-450 CYP3A Inhibitors; D005473:Fluoxetine; D017367:Selective Serotonin Reuptake Inhibitors; D014221:Triamcinolone; C510163:CYP3A4 protein, human